Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 90702 | 3-(4-Acetoxyphenyl)propanoic acid | 7249-16-3 | 98% | propanoicacid-cas-7249-16-3.png) |
| Coming soon! | ||||
| 90607 | 3-(3-Aminophenyl)propanoic acid | 1664-54-6 | 98% | propanoicacid-cas-1664-54-6.png) |
| Coming soon! | ||||
| 90102 | 3-Azetidinecarboxylic Acid | 36476-78-5 | 98% |  |
| Coming soon! | ||||
| 83110 | 1-aminocyclohexane-1-carboxylic acid | 2756-85-6 | 98% |  |
| Coming soon! | ||||
| 83109 | 2-amino-2-ethylbutanoic acid | 2566-29-2 | 98% |  |
| Coming soon! | ||||
| 82801 | 8-(2-aminoethyl)-5-hydroxy-4H-1,4-benzoxazin-3-one,hydrochloride | 1035229-35-6 | 98% | -5-hydroxy-4H-14-benzoxazin-3-onehydrochloride-cas-1035229-35-6.png) |
| Coming soon! | ||||
| 82708 | Aliskiren | 173334-57-1 | 98% |  |
| Aliskiren(CGP 60536) is a direct renin inhibitor with IC50 of 1.5 nM. | ||||
| 82706 | Abiraterone | 154229-19-3 | 98% |  |
| Abiraterone is a potent steroidal cytochrome P450 17alpha-hydroxylase-17,20-lyase (CY | ||||
| 82702 | AT7519 Hydrochloride | 902135-91-5 | 98% |  |
| AT7519 hydrochloride is a multi-CDK inhibitor for CDK1, 2, 4, 6 and 9 with IC50 of 10 | ||||
| 82405 | AZ191 | 1594092-37-1 | 98% |  |
| AZ191 selectively inhibits DYRK1B serine/threonine kinase activity with no effect on | ||||
| 81940 | 4-Amino-2,3-dihydro-1H-inden-1-one | 51135-91-2 | 98% |  |
| Coming soon! | ||||
| 81928 | 6-Aminoindan-1-one | 69975-65-1 | 98% |  |
| Coming soon! | ||||
| 81805 | 4-Amino-Piperidine-1-Carboxylic Acid Benzyl Ester | 120278-07-1 |  | |
| Coming soon! | ||||
| 81720 | 2-Amino-5-chloro-3-methylbenzoic acid | 20776-67-4 | 98% |  |
| Coming soon! | ||||
| 81707 | 2-Aminomethyl-1-Boc-piperidine | 370069-31-1 | 98% |  |
| Coming soon! | ||||
| 81304 | 2-Amino-4'-fluorobenzophenone | 3800-06-4 | 98% |  |
| Related API & intermediates:Cas#147526-32-7 Pitavastatin CalciumCas# 24922-02-9 E | ||||
| 81012 | 4-Acetoxy-3-bromobenzoic acid | 72415-57-7 | 97% |  |
| Coming soon! | ||||
| 80702 | AC710 | 1351522-04-7 | 97% |  |
| AC710 is a potent, selective PDGFR-family kinases inhibitor with Kd values of 0.6 nM/ | ||||
| 80311 | 4-Amino-3-iodobenzoic acid | 2122-63-6 | 97% |  |
| Coming soon! | ||||
| 80302 | ALPHA-BENZYL-4,6-O-BENZYLIDENE-MURAMIC ACID | 19229-57-3 | 97% |  |
| Coming soon | ||||
| 71804 | AZD2014(Vistusertib) | 1009298-59-2 | 98% by HPLC |  |
| AZD2014is a potent (IC50 2.81 nM), selective (inactive against 220 other kinases) inh | ||||
| 71802 | AZD9496 | 1639042-08-2 | 98% |  |
| 1) Sponsor:AstraZeneca2) Phase:Phase 13)AZD9496 is a novel, oral selective oestrogen | ||||
| 62504 | Alpelisib(BYL719) | 1217486-61-7 | >98% by HPLC | -cas-1217486-61-7.png) |
| NVP-BYL719 is novel and specific PI3K inhibitor.NVP-BYL719 has displayed promising re | ||||
| 62503 | Apitolisib(GDC-0980,RG7422) | 1032754-93-0 | >98% by HPLC | -cas-1032754-93-0.png) |
| Apitolisib(GDC-0980,RG7422) is a dual PI3K/mTOR inhibitor.GDC-0980 was potent across | ||||
| 61005 | Atazanavir | 198904-31-3 | 98% |  |
| Atazanavir(BMS-232632) is an highly potent HIV-1 protease inhibitor. | ||||
| 60702 | Abexinostat | 783355-60-2 | 96% |  |
| Abexinostat is a novel hydroxamate-based HDACi that showed broad spectrum anticancer | ||||
| 52771 | Axitinib | 319460-85-0 | 98% |  |
| Axitinib, also known as AG013736, is an orally bioavailable tyrosine kinase inhibitor | ||||
| 52770 | AVL-292 | 1202757-89-8 | 98% |  |
| AVL-292 is a covalent, highly selective, orally active small molecule inhibitor of Bt | ||||
| 52769 | AT9283 | 896466-04-9 | 98% |  |
| AT9283 is a small molecule a multi-targeted inhibitor with IC50s of 4, 1.2, 1.1 and a | ||||
| 52768 | AT13387 | 912999-49-6 | 98% |  |
| AT13387 is a selective potent Hsp90 inhibitor with IC50 of 18 nM in A375 cells, displ | ||||